# Senate health panel delays vote on CDC nominee
Canonical URL: https://biopharmsignal.com/news/MARKET/senate-health-panel-delays-vote-on-cdc-nominee-6cfcdaaa
Ticker: MARKET
Company: MARKET
Source: STAT News
Published: 2026-07-23 16:18 EST
Original Source URL: https://www.statnews.com/2026/07/23/erica-schwartz-cdc-director-vote-delayed/?utm_campaign=rss
## Summary

Too few senators were in attendance to proceed with a vote on the CDC director nominee.

## Article Body
WASHINGTON — The Senate’s health panel delayed until next week a vote on Erica Schwartz to run the Centers for Disease Control and Prevention, after postponing a separate vote on Sean Kaufman for a key public health preparedness role.

The committee vote on Schwartz was pushed back because too few senators showed up. Sen. Lisa Murkowski (R-Alaska) is dealing with a family emergency, and at least one other lawmaker was also absent.

Earlier on Thursday, health committee chair Sen. Bill Cassidy (R-La.) said he had enough votes to advance Schwartz out of the committee, where the GOP holds a one-vote advantage.

Cassidy told reporters he delayed the vote on Kaufman to be assistant secretary for preparedness and response because he hadn’t done a count of how much support Kaufman had. A Senate health committee spokesperson said that the committee and the administration were looking into a “path forward” for Kaufman. When asked what that might look like, Cassidy responded: “TBD.”

Schwartz was deputy surgeon general during the first Trump administration. During her confirmation hearing , she spoke about scaling up drive-thru Covid-19 testing during the pandemic as well as her experience in health roles in the U.S. military.
## Recent Company News
- 2026-07-23 16:33 EST — [STAT+: European regulators take steps to bolster clinical trial transparency](https://biopharmsignal.com/news/MARKET/stat-european-regulators-take-steps-to-bolster-clinical-trial-transparency-73aade26) — Source: STAT News
- 2026-07-23 16:23 EST — [STAT+: Popular insulin product enters shortage as other pens leave market](https://biopharmsignal.com/news/MARKET/stat-popular-insulin-product-enters-shortage-as-other-pens-leave-market-c3a6a199) — Source: STAT News
- 2026-07-23 16:18 EST — [Senate health panel delays vote on CDC nominee](https://biopharmsignal.com/news/MARKET/senate-health-panel-delays-vote-on-cdc-nominee-6cfcdaaa) — Source: STAT News
- 2026-07-23 15:26 EST — [STAT+: What’s in the last-minute flurry of health care bills?](https://biopharmsignal.com/news/MARKET/stat-what-s-in-the-last-minute-flurry-of-health-care-bills-39fec163) — Source: STAT News
- 2026-07-23 14:58 EST — [FDA panel confronting peptide controversy](https://biopharmsignal.com/news/MARKET/fda-panel-confronting-peptide-controversy-b9e91564) — Source: STAT News
## Related News
- 2026-07-23 16:33 EST — MARKET — [STAT+: European regulators take steps to bolster clinical trial transparency](https://biopharmsignal.com/news/MARKET/stat-european-regulators-take-steps-to-bolster-clinical-trial-transparency-73aade26)
- 2026-07-23 16:30 EST — BRLI — [OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026](https://biopharmsignal.com/news/BRLI/opko-health-to-report-second-quarter-2026-financial-results-on-july-27-2026-4b38e04c)
- 2026-07-23 16:23 EST — MARKET — [STAT+: Popular insulin product enters shortage as other pens leave market](https://biopharmsignal.com/news/MARKET/stat-popular-insulin-product-enters-shortage-as-other-pens-leave-market-c3a6a199)
- 2026-07-23 15:26 EST — MARKET — [STAT+: What’s in the last-minute flurry of health care bills?](https://biopharmsignal.com/news/MARKET/stat-what-s-in-the-last-minute-flurry-of-health-care-bills-39fec163)
- 2026-07-23 14:58 EST — MARKET — [FDA panel confronting peptide controversy](https://biopharmsignal.com/news/MARKET/fda-panel-confronting-peptide-controversy-b9e91564)